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Table 1: Patient Characteristics 
Characteristic     Value  
Median Age 64 years IQR 59-69 
Median PSA at imaging 0.42ng/mL IQR 0.29-0.93 
Median PSA doubling time 5 months IQR 3.3- 7.6 
Tumour stage   
T2 34 37.4% 
T3a 35 39.5% 
T3b 21 23% 
Positive surgical margins 27 29.7% 
Gleason score   
6-7 60 67% 
8-10 29 32% 
Median months since RP 23 IQR 9 – 46.5 
Treatment Received   
No treatment administered 19 21% 
Salvage fossa RTX 44 48% 
Fossa + pelvic nodal RTX 8 9% 
RTX fossa /nodes + ADT 16 17% 
ADT alone 4 5% 
 
 
 
 
  
 
 
 
 
 
 
 
Figure 1. Flow chart for determining the composite reference standard used in 
assessment of diagnostic accuracy for PSMA, FCH and pelvic MRI. 
 
 
 
 
 
 
 
 
Table 2: Per patient detection rates for PF and extra PF disease by imaging modality 
(FCH, PSMA and pelvic MRI) 
 
Modality Fossa 
recurrence 
Extra PF Fossa + Extra PF 
Pelvic MRI 19/88 (21.5%) 7/88 (8%) 25/88 (28%) 
FCH 12/91 (12%) 17/91 (19%) 29/91 (32%) 
PSMA 6/31 (19%) 10/31 (32%) 13/31 (42%) 
Overall 27/91 (30%) 21/91 (23%) 48/91 (53%) 
 
  
 
 
 
Table 3. Per patient comparison tables of FCH and MRI (A) and FCH and PSMA (B)  
for detection rates of Negative or Fossa confined disease and Extra-PF disease.  
 
Modality (A) FCH neg or fossa confined FCH extra-PF  
MRI neg or fossa confined 69 12 81  
MRI extra-PF 2 5 7 
 71 17 88 
 
Modality (B) FCH neg or fossa confined FCH extra-PF  
PSMA neg or fossa confined 20 1 21 
PSMA extra-PF 1 9 10 
 21 10 31 
 
 
 
Table 4.  Per patient diagnostic accuracy for FCH, PSMA and Pelvic MRI for Extra -
PF prostate cancer in men with BCR post RP and negative/equivocal conventional 
imaging.  
Modality Sensitivity Specificity NPV PPV 
Pelvic MRI 19% 97% 66%  80% 
FCH 47.8% 97% 73.9% 91.7% 
PSMA 66.67% 100% 50% 100% 
 
 Figure 2. 
A 67 year old man with GSC 8 PCa, PSA 0.29ng/mL 5 years post RP. Imaging 
demonstrates a prostate fossa recurrence on FCH, PSMA and pelvic MRI (A), which 
entirely resolved on repeat PSMA following SRT to the prostate fossa (B). A solitary 
PSMA avid, FCH and MRI negative T11 focus was persistent on repeat imaging at 3 
months and confirmed True positive (C). This focus was negative on thoracic spine 
MRI (D). 
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Figure 3.  Treatment response to targeted SRT stratified by imaging result (Negative 
or fossa confined vs. Extra-PF disease) for pelvic MRI, FCH and PSMA. 
 
 
 
 
 
 
*p < 0.02    ***p < 0.005 
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